Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial of Additional Left Atrial Posterior Wall Isolation for Persistent Atrial Fibrillation

NCT04405258 is registered in ClinicalTrials.gov with Institute for Clinical Effectiveness, Japan as lead sponsor.

NCT NCT04405258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial of Additional Left Atrial Posterior Wall Isolation for Persistent Atrial Fibrillation
Lead sponsor
Institute for Clinical Effectiveness, Japan
Phase
Phase 4
Overall status
Unknown status
Start date
June 8, 2020
Completion date
June 30, 2026
Enrollment
276 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

catheter ablation, persistent atrial fibrillation, posterior wall isolation, pulmonary vein isolation